Book contents
- Frontmatter
- Contents
- Contributors
- Foreword
- Acknowledgements
- Biographical note on F. H. Lewy
- Abbreviations
- Group photograph
- Introduction
- Part one Clinical issues
- Part two Pathological issues
- 15 Pathological significance of Lewy bodies in dementia
- 16 Tautological tangles in neuropathologic criteria for dementias associated with Lewy bodies
- 17 What is the neuropathological basis of dementia associated with Lewy bodies?
- 18 Cytoskeletal and Alzheimer-type pathology in Lewy body disease
- 19 Diffuse Lewy body disease within the spectrum of Lewy body disease
- 20 Temporal lobe immunohistochemical pathology for tangles, plaques and Lewy bodies in diffuse Lewy body disease, Parkinson's disease, and senile dementia of Alzheimer type
- 21 Pathological and clinical features of Parkinson's disease with and without dementia
- 22 Dementia with Lewy bodies: relationships to Parkinson's and Alzheimer's diseases
- 23 What do Lewy bodies tell us about dementia and parkinsonism?
- 24 Pathogenesis of the Lewy body
- 25 Altered tau processing: its role in development of dementia in Alzheimer's disease and Lewy body disease
- 26 Cytoskeletal pathology in Alzheimer's disease and Lewy body dementia – an epiphenomenon?
- 27 Genetic correlations in Lewy body disease
- Résumeacute; of pathological workshop sessions
- Part three Treatment issues
- Appendices
- Index
- Plate section
22 - Dementia with Lewy bodies: relationships to Parkinson's and Alzheimer's diseases
from Part two - Pathological issues
Published online by Cambridge University Press: 06 July 2010
- Frontmatter
- Contents
- Contributors
- Foreword
- Acknowledgements
- Biographical note on F. H. Lewy
- Abbreviations
- Group photograph
- Introduction
- Part one Clinical issues
- Part two Pathological issues
- 15 Pathological significance of Lewy bodies in dementia
- 16 Tautological tangles in neuropathologic criteria for dementias associated with Lewy bodies
- 17 What is the neuropathological basis of dementia associated with Lewy bodies?
- 18 Cytoskeletal and Alzheimer-type pathology in Lewy body disease
- 19 Diffuse Lewy body disease within the spectrum of Lewy body disease
- 20 Temporal lobe immunohistochemical pathology for tangles, plaques and Lewy bodies in diffuse Lewy body disease, Parkinson's disease, and senile dementia of Alzheimer type
- 21 Pathological and clinical features of Parkinson's disease with and without dementia
- 22 Dementia with Lewy bodies: relationships to Parkinson's and Alzheimer's diseases
- 23 What do Lewy bodies tell us about dementia and parkinsonism?
- 24 Pathogenesis of the Lewy body
- 25 Altered tau processing: its role in development of dementia in Alzheimer's disease and Lewy body disease
- 26 Cytoskeletal pathology in Alzheimer's disease and Lewy body dementia – an epiphenomenon?
- 27 Genetic correlations in Lewy body disease
- Résumeacute; of pathological workshop sessions
- Part three Treatment issues
- Appendices
- Index
- Plate section
Summary
Summary
Among 290 demented subjects in a consecutive autopsy series of elderly individuals with or without parkinsonian signs, 41 cases or 14.1% showed abundant subcortical and cortical Lewy bodies satisfying the diagnosis of Lewy body dementia (LBD) they represented 35.7% of demented patients with parkinsonism (54% of those with idiopathic Parkinson's disease) (IPD) and 26.1% of confirmed cases of Alzheimer's disease (AD) with parkinsonism. Both elderly subjects without clinical parkinsonism (n = 83) and IPD patients (” = 39) showed significant negative correlations between Mini-Mental State and neuritic Alzheimer stages, while 10 of 18 LBD cases clinically presenting with IPD and dementia did not satisfy the CERAD criteria for AD but represented ‘plaque-only’ type of AD. The 41 cases of autopsy-proven LBD showed a female preponderance (31/10), mean age at death of 76 + 10.8 years and mean duration of 5.2 + 4.1 years. Among 31 clinically well documented LBD cases, all except 4 were severely demented, with initial cognitive impairment in 58%, parkinsonian symptoms in 26%, and later combination of both in 84%. Neuropathology revealed LBD without AD pathology in one, LBD with ‘plaque-predominant’ AD and CERAD-definite AD in 15 cases each. Morphometric analyses showed about 70% neuronal loss in the cholinergic nucleus basalis of Meynert in LBD, demented IPD, and AD cases. While these data suggest the importance of both cortical AD pathology and dysfunction of the ascending cholinergic system for mental decline in these disorders, both the significance of cortical Lewy bodies and the pathogenic relationships between IPD, LBD and LBD + AD await further elucidation.
- Type
- Chapter
- Information
- Dementia with Lewy BodiesClinical, Pathological, and Treatment Issues, pp. 268 - 286Publisher: Cambridge University PressPrint publication year: 1996
- 11
- Cited by